Phase 2 Study of CD19 CAR T Cells with a Fully Human Binder for Large B-Cell Lymphoma in Relapse or Progression after a Murine Binder-Bearing CD19 CAR T-Cell TherapyJordan Gauthier, Cameron J. Turtle, Jennifer J. Huang et al.|Blood|2023Cited by 0
Safety and Efficacy of Fully-Human-Binder-Bearing CD19 CAR T-Cell Therapy for Large B-Cell Lymphoma after Failure of Murine-Binder-Bearing CD19 CAR T-Cell TherapyJennifer J. Huang, Cameron J. Turtle, Aiko Torkelson et al.|Transplantation and Cellular Therapy|2024Cited by 0
TNFα Apoptotic Signaling By Antigen-Engaged CAR T-Cells Mediates Clearance of Target Antigen-Negative Acute Myeloid LeukemiaErik L. Kimble, Cameron J. Turtle, Salvatore Fiorenza et al.|Blood|2024Cited by 0
CAR T-Cell Therapy for Acute Myeloid Leukemia: Critical Role for TNFα Signaling to Overcome Target Antigen HeterogeneityErik L. Kimble, Cameron J. Turtle, Salvatore Fiorenza et al.|Transplantation and Cellular Therapy|2025Cited by 0